Crossmark

Spikevax booster and delayed urticaria: a Swiss signal with diagnostic uncertainties due to a high proportion of direct patient reports

Published Online: 2022-10-18

Published Print: 2022-12

Authors

Noseda, Roberta https://orcid.org/0000-0002-4946-7926
Müller, Laura

Stammschulte, Thomas

Bertoli, Raffaela

Ceschi, Alessandro https://orcid.org/0000-0002-4308-0405
License Information

Text and Data Mining valid from 2022-10-18

Version of Record valid from 2022-10-18
More Information

Article History

Received: 7 July 2022

Accepted: 11 October 2022

First Online: 18 October 2022

Declarations

:

: The authors declare no competing interests.

Document is current